Bull Ecol Soc Am 80:231–234CrossRef Scarascia-Mugnozza G, Oswald

Bull Ecol Soc Am 80:231–234CrossRef Scarascia-Mugnozza G, Oswald H, Piussi P, Radoglou K (2000) Forests of the Mediterranean region: gaps in knowledge and research needs. For Ecol Manag 132:97–109CrossRef Schnitzler A, Hale BW, Alsum EM (2007) Examining native and exotic species diversity in European riparian forests. Biol Conserv

138:146–156CrossRef Schröter D, Cramer W, Leemans R, Prentice C, Araújo MB, Arnell NW, Bondeau A, Bugmann H, Carter TR, Gracia CA, Vega-Leinert ACdl, Erhard M, Ewert F, Glendining M, House JI, Kankaanpää S, Klein RJT, Lavorel S, compound screening assay Lindner M, Metzger MJ, Meyer J, Mitchell TD, Reginster I, Rounsevell M, Sabaté S, Sitch S, Smith B, Smith J, Smith P, Sykes MT, Thonicke K, Thuiller W, Tuck G, Zaehle S, Zierl B (2005) Ecosystem service supply and vulnerability to global change in Europe. Science 310:1333–1337CrossRefPubMed Spackman SC, Hughes JW (1994) Assessment of minimum stream corridor width for biological conservation: species richness and distribution along mid-order streams in Vermont, USA. Biol Conserv 71:325–332CrossRef Tabacchi E, Correll DL, Hauer R, Pinay G, Planty-Tabacchi A-M, Wissmar RC (2002) Development, maintenance and role of riparian vegetation in the river landscape. Freshw Biol 40:497–516CrossRef Vallentine JF (2001) Grazing management. Academic Press, San Diego selleck inhibitor Virgós E (2001) Relative value of riparian

woodlands in landscapes with different forest cover for medium-sized Iberian carnivores. Biodiv Conserv 10:1039–1049CrossRef

Williams P, Whitfield M, Biggs J, Bray S, Fox G, Nicolet P, Sear D (2003) Comparative biodiversity of rivers, streams, ditches and ponds in an agricultural landscape in Southern England. Biol Conserv 115:329–341CrossRef Zar JH (1999) Biostatistical analysis. New Jersey”
“Introduction There is a lot of ongoing debate regarding the explanation of plant and animal diversification in the Amazon basin and adjacent Guianas. Several historical biogeographic scenarios have been suggested (e.g. Haffer 1997, 2008; Hall and Harvey 2002; Noonan and Wray 2006). This paper focuses on the disturbance vicariance hypothesis (DV), which is described by Bush (1994), Noonan and Gaucher (2005) and Haffer (2008) derived from MYO10 pollen analyses and patterns of species phylogenies. DV explains incomplete speciation in taxa on the eastern Guiana Shield due to relatively short phases of climate change during Pleistocene. During interglacials, cool-adapted species were retracted to higher elevations and allopatric speciation started, a process which was interrupted (‘disturbed’) as renewed glacials allowed for secondary contact via lowlands. Such a scenario, for instance, is suggested for caesalpinioid trees (Dutech et al. 2003) or bufonid and dendrobatid frogs (Noonan and Gaucher 2005, 2006). According to Bush (1994) and Noonan and Gaucher (2005), cool-adapted Guiana Shield taxa, which have undergone DV, are of Andean origin.

Nat Rev Microbiol 2008, 6:441–454 PubMed 2 Nemati M, Jenneman GE

Nat Rev Microbiol 2008, 6:441–454.PubMed 2. Nemati M, Jenneman GE, Voordouw G: Mechanistic study of microbial control of hydrogen sulfide production in oil reservoirs. Biotechnol Bioeng 2001, 74:424–434.PubMedCrossRef 3. Videla HA, Herrera LK: Microbiologically influenced corrosion: looking to the future. Int Microbiol 2005, 8:169–180.PubMed 4. Korenblum E, Valoni E, Penna M, Seldin L: Bacterial diversity in water injection systems of Brazilian offshore oil platforms. Appl Microbiol Biotechnol 2010, 85:791–800.PubMedCrossRef 5. Videla HA: Prevention and control of biocorrosion. Inter Biodeterd Biodegrad 2001, 4:259–270. 6. NACE International – the corrosion https://www.selleckchem.com/products/PLX-4032.html societyhttp://​www.​nace.​org/​

7. Ongena M, Jacques P: Bacillus lipopeptides: versatile weapons for plant disease biocontrol.

Trends Microbiol 2008, 16:115–125.PubMedCrossRef 8. Abriouel H, Franz CM, Ben Omar N, Gálvez A: Diversity and applications of Bacillus bacteriocins. FEMS Microbiol Rev 2011, 35:201–232.PubMedCrossRef 9. Cherif A, Chehimi S, Limem F, Hansen BM, Hendriksen NB, Daffonchio D, Boudabous A: Detection and characterization of the novel bacteriocin entomocin 9, and safety evaluation of its producer, Bacillus thuringiensis ssp. entomocidus HD9. J Appl Microbiol 2003, 95:990–1000.PubMedCrossRef 10. Hyronimus B, Le Marrec C, Urdaci MC: Coagulin, a bacteriocin-like inhibitory substance produced by Bacillus coagulans I4. SCH772984 mw J Appl Microbiol 1998, 85:42–50.PubMedCrossRef 11. Korenblum E, der Weid I, Santos AL, Rosado AS, Sebastián GV, Coutinho CM, Magalhães FC, Paiva MM, Seldin L: Production of antimicrobial substances by Bacillus

subtilis LFE-1, B. firmus HO-1 and B. licheniformis T6–5 isolated from an oil reservoir in Brazil. J Appl Microbiol 2005, 98:667–675.PubMedCrossRef 12. Naruse N, Tenmyo O, Kobaru S, Kamei H, Miyaki T, Konishi M, Oki T: Pumilacidin, a complex of new antiviral antibiotics. Production, isolation, chemical properties, structure and biological activity. J Antibiot (Tokyo) 1990, 43:267–280.CrossRef 13. Stein T: Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol Microbiol 2005, 56:845–857.PubMedCrossRef 14. Tagg JR, Dajani AS, Wannamaker LW: Bacteriocins of gram-positive bacteria. Bacteriol Rev 1976, 40:722–756.PubMed 15. Azuma T, Harrison Progesterone GI, Demain AL: Isolation of a gramicidin S hyperproducing strain of Bacillus brevis by use of a fluorescence activated cell sorting system. Appl Microbiol Biotechnol 1992, 38:173–178.PubMedCrossRef 16. Fujita-Ichikawa Y, Tochikubo K: Quantitative analysis of polymyxin B released from polymyxin B-treated dormant spores of Bacillus subtilis and relationship between its permeability and inhibitory effect on outgrowth. Microbiol Immunol 1993, 37:935–941.PubMed 17. Arima K, Kakinuma A, Tamura G: Surfactin, a crystalline peptidelipid surfactant produced by Bacillus subtilis: isolation, characterization and its inhibition of fibrin clot formation. Biochem Biophys Res Commu 1968, 31:488–494.CrossRef 18.

Several studies have reported the usefulness of phage-display app

Several studies have reported the usefulness of phage-display applications for mapping epitopes of flaviviruses [[22–25]]. The aim of our study was to identify WNV-specific and/or JEV serocomplex-specific B-cell epitopes in NS1 using phage display technology. The information provided by this study will facilitate the development of diagnostic tools for the specific serological diagnosis of WNV infection, and will contribute to PD-1 antibody the rational design of vaccines by furthering understanding

of the antigenic structure of NS1. Results Production of recombinant NS1 Recombinant WNV NS1 was successfully expressed in E. coli TB1 cells, predominantly as soluble protein, after induction with isopropyl β-D-1-thiogalactopyranoside (IPTG). The recombinant protein was recognized by WNV-positive equine serum in Western blot (WB) (Figure 1, lane 1). Figure 1 WNV-positive equine sera Maraviroc mouse recognize recombinant NS1. Binding of antibodies from WNV-positive equine serum

to recombinant NS1 (lane 1) and MBP-tag (lane 2) by Western blot. M, PageRuler™ Prestained Protein Ladder (Fermentas, Canada). Production and characterization of NS1-specific mAbs Purified protein was used to immunize BALB/c mice. After cell fusion and screening, several hybridoma cell lines were obtained which produced NS1-specific mAbs. Among them two cell lines were selected for their strongest reactivity against recombinant NS1 using indirect ELISA (data not shown), WB (Figure 2a), and against native NS1 in IFA using WNV antigen slides (Figure 2b). Further characterization of the specificity of the two mAbs by IFA, demonstrated that the mAb 3C7 reacted with WNV, but did not react with JEV, DENV1-4, Yellow fever virus (YFV) and Tick-borne encephalitis virus (TBEV), whereas mAb 4D1 reacted with both WNV and JEV, but did not react

with other non-JEV serocomplex flaviviruses (Figure 2b). Figure 2 Reactivity of mAbs with recombinant NS1 and C6/36 cells infected with flaviviruses. (a) Western blot analysis of mAbs 3C7 (lanes 1, 2) and 4D1 (lanes 3, 4) against recombination NS1 (lane 1, 3) and MBP-tag (lane 2, 4). M, PageRuler™ Prestained Protein Ladder (Fermentas, Canada). (b) Pattern of immunofluorescence JAK inhibitor produced by anti-NS1 mAbs on antigen slides which were prepared on porous slides using C6/36 cells infected with different flaviviruses. Panels 1-8: reactivity of mAb 3C7 with cells infected with WNV (panel 1), JEV (panel 2), DENV1 (panel 3), DENV2 (panel 4), DENV3 (panel 5), DENV4 (panel 6), YFV (panel 7), and TBEV (panel 8). Panels 11-18: reactivity of mAb 4D1 with cells infected with WNV (panel 11), JEV (panel 12), DENV1 (panel 13), DENV2 (panel 14), DENV3 (panel 15), DENV4 (panel 16), YFV (panel 17), and TBEV (panel 18).

The size distribution of supported gold nanoparticles was evaluat

The size distribution of supported gold nanoparticles was evaluated by a statistical measurement of 300 randomly selected particles, which can be found in Figure 2d. These particles are in the range 2 to 8 nm and the average size centers at 4.1 nm. Figure 1 XRD patterns of HNTs and Au/HNTs. Black circle, metallic Au. Figure 2 TEM images of the HNTs and Au/HNTs and size distribution . (a) Pure HNTs. (b) Gold nanoparticles in the HNTs. (c)

High-resolution TEM image of gold nanoparticles. (d) Size distribution of supported gold nanoparticles. Figure 3 shows the representative Au 4f core level XPS spectrum of the Au/HNTs catalyst. Broad peaks of Au 4f7/2 and Au 4f5/2 states were observed in the Au/HNTs sample, indicating the presence of both metallic Proteasome inhibitor and ionic gold species [12, 13]. In addition to the main peak characteristic of metallic Au0, the XPS spectra also contain the 4f7/2 signals from Au1+ ions [12, 13]. The deconvolution analysis results of the Au 4f spectra of the Au/HNTs catalysts showed that about 60% of the gold species are oxidized Au1+ species. Similar to our findings, Abad et al. have recently shown by XPS and IR spectroscopy the presence of positive gold ions in Au/CeO2 catalyst [14]. Such species has been suggested to be of vital importance in the rate-controlling step during the oxidation of alcohols involving the hydride shift from alcohol to gold [15]. Figure 3 Representative Au 4f core level XPS

spectrum of Au/HNTs. For the Au/HNTs catalyst, solvent-free aerobic oxidation of Selleck Trichostatin A benzyl alcohol which is often employed as a model reaction for alcohol oxidation was chosen to test its catalytic activity [16–18]. The control experiments using the

pure HNTs reveal that less than 2% of the benzyl alcohol can be selectively these converted to benzaldehyde within 8 h at 110°C. Figure 4 shows a typical set of results for benzyl alcohol conversion over the Au/HNTs catalyst, illustrating the dependence of conversion and selectivity on the reaction time. As the reaction proceeded, the conversion of benzyl alcohol and the selectivity to benzyl benzoate increased, while the selectivity to benzaldehyde decreased. Enache et al. [17] and Abad et al. [14] have recently reported very high turnover frequency (TOF) values in the solvent-free oxidation of benzyl alcohol at about 100°C for Au-Pd/TiO2 (TOF = 607 h−1) and Au/CeO2 (TOF = 150 h−1) catalysts, respectively. To compare with other reported catalysts, the catalytic performance of the Au/HNTs catalyst in the solvent-free aerobic oxidation of benzyl alcohol at 110°C under atmospheric pressure was also investigated. The results showed that the Au/HNTs catalyst exhibited a specific rate of 307 h−1 under similar reaction conditions. This value compares favorably with the results reported on Au/CeO2 catalysts [17], demonstrating that our catalytic system can serve as a promising catalyst for the selective oxidation of alcohols.

7 ± 5 9% Follow up was available for 87 patients and ranged from

7 ± 5.9%. Follow up was available for 87 patients and ranged from 1 to 165 months (median 64 months). Survival time was calculated from the date of surgery to the date of death or of the last follow up. The expression of HIF-1α, VEGF-A and VEGF-C in carcinoma cells was compared to tumor variables that represent prognostic factors in CRCC: nuclear grade,

Gefitinib clinical trial tumor size, Ki67 proliferative index and pathologic stage (Table 2). Table 2 Relation of HIF-1α, VEGF-A and VEGF-C to clinicopathologic parameters     Nuclear grade1 P value Tumor size (cm)1 p value Ki67 (%)1,2 P value Pathologic stage1 P value     1,2 3,4   < 7 ≥ 7   low high   1 2,3,4,   HIF-1α nHIF-1α 49.5 39 0.006 48.6 43.6 0.057 43.9 48.1 0.134 48.1 44.5 0.165 (%)   (16.3–82.3) (19.2–72.6)   (27.9–73.9) (16.3–82.3)   (16.3–72.4) (21.2–82.3)   (27.9–73.9) (16.3–82.3)     cHIF-1α 11.4 18.7 0.006 11.3 Selleck LY2157299 17.5 0.009 14.6 11.6 0.246 11.4 16.6 0.023     (1.4–75) (5.2–59.5)   (1.4–59.5) (2.9–75)   (4.3–75) (1.4–46.5)   (1.4–42.6) (2.9–75)   VEGF-A pVEGF-A 15 12.5 0.307 15 7.5 0.173 12.5 12.7 0.658 12.1 17.5 0.682 (%)

  (0.00–94) (0–75)   (0–94) (0–75)   (0–94) (0–75)   (0–94) (0–75)     dVEGF-A 6.7 30 <0.001 6.7 16.7 0.015 10.6 10 0.652 6.3 11.7 0.027     (0–92.5) (0–90)   (0–67.5) (0–92.5)   (0–92.5) (0–83.3)   (0–76.7) (0–92.5)   VEGF-C pVEGF-C 65 14 <0.001 64.2 27.9 0.007 45 55 0.913 61.3 33.3 0.042 (%)   (0–100) (0–92.5)   (0–100) (0–100)   (0–100) (0–100)   (0–100) (0–100)     dVEGF-C 18.5 37 0.004 18 37.1 0.007 25

26.3 0.516 20 30 0.109     (0–100) (0–100)   (0–100) (0–100)   (0–100) (0–100)   (0–100) (0–100)   1Mann-Whitney U-test; median (range);2cut-off is mean Nuclear HIF-1α and pVEGF-C expression was associated with lower nuclear grade and smaller tumor size indicating better prognosis, while cHIF-1α together with dVEGF-A and -C was associated with worse prognostic factors, i.e. higher nuclear grade, larger tumor size and higher tumor stage. There was no association of Ki67 index with either protein analyzed. Association of HIF-1α, VEGF-A and -C with patient survival The association of immunohistochemical cAMP positivity for HIF-1α, VEGF-A and VEGF-C and cumulative proportion of patients surviving during the follow up are shown in Figure 2. Figure 2 Kaplan-Meier cumulative survival analysis according to staining for nuclear and cytoplasmic HIF-1α, VEGF-A and VEGF-C. The log-rank test showed significantly shorter overall survival in patients with tumors showing low nHIF-1α (p = 0.005) (A) and low pVEGF-C (p = 0.008) (D). The 5-year survival rate was 32% for patients whose tumors showed low nHIF-1α vs. 65% for patients whose tumors showed high nHIF-1α (A); and 40% for patients whose tumors showed low pVEGF-C vs. 61% for patients whose tumors showed high pVEGF-C (D). The log-rank test showed significantly shorter overall survival in patients with tumors showing high cHIF-1α (p = 0.018) (B) and high dVEGF-A (p = 0.024) (C).

Whilst none of the risk estimates was significantly different, a

Whilst none of the risk estimates was significantly different, a clear trend was evident and this supports the possibility that stronger

inhibition of the 5-HTT system on the bone could cause a greater disruption of the balance between osteoblasts click here and osteoclasts and hence have a greater detrimental effect on bone micro-architecture. Drug-induced changes in bone micro-architecture can be rapid. Analysis of the micro-architecture of femur bone in rats treated with 5-HT showed changes in trabecular bone volume and an increased femoral stiffness after just 3 months [10]. Other drug exposures had demonstrated similarly rapid effects on human bone, e.g. corticosteroids [42, 43]. It is possible that a rapid change in bone micro-architecture affected by anti-depressant use accounted for, or at least contributed to, the increased fracture risk during the early months of exposure. We found that as the duration of treatment with TCAs increased, the risk of fracture declined, whereas the risk for fracture with continuation of SSRIs fell after the initial increase but remained somewhat elevated thereafter.

It may be that with chronic administration of anti-depressants, adaptive changes occur [44]. These may result in an adjustment to the cardiovascular effect of TCAs and SSRIs, explaining the decrease in fracture risk after a few months of use, whereas changes in bone physiology are not subject to adaptive changes, explaining the sustained find more fracture risk in SSRI users. Limitations of our study include absence of potentially confounding data on body mass index (BMI), smoking status and exercise. In a US/Puerto Rican cohort study, it was likely that lack of adjustment for BMI, current smoking status, activities of daily living score, cognitive impairment and Rosow–Breslau physical impairment scale accounted for up to 30% of the increased risk of hip fractures amongst users of SSRIs [45]. We do not anticipate that missing data on these variables would have an important impact on our findings; therefore, as if our ORs were decreased by 30%, a positive association would remain. Another limitation lies in the potential for confounding by

indication, as depression Tyrosine-protein kinase BLK itself is associated with an increased risk of falls and fractures [46]. There is also the possibility of a channelling effect whereby, for some frail patients with depression, an SSRI was prescribed instead of a TCA because of the more favourable side-effect profile anticipated. This could have overestimated the risk associated with SSRIs observed here. These unmeasured types of confounding as well as selection bias (e.g. healthy user bias), which can change over time, may be alternative explanations for our observed associations between fracture risk and duration of anti-depressant use or discontinuation of anti-depressants. In Figs. 1 and 2, data beyond 4 years are sparse, which makes extrapolation uncertain. Lastly, the PAR calculation showed that 4.

In the 1974′-*s, studies identified that the most common pathophy

In the 1974′-*s, studies identified that the most common pathophysiologic mechanism is an intimal tear with subsequent thrombosis. While the symptoms are generally those of carotid insufficiency, a diagnosis of cervical carotid trauma is seldom made clinically because the entity is confused with intracranial injury [2, 6]. Several laboratory tests and imaging studies are frequently CP-673451 order required in the emergency room for the evaluation of trauma. However, imaging exams to identify cervical vessel lesions are not performed routinely during initial trauma care. Angiography is considered the

‘gold standard’ exam for the identification of vascular lesions. The duplex scan has 86% sensitivity, but is limited in its ability to identify carotid artery lesions near the base of the skull. Angiotomography is sensitive enough to identify general anatomical click here lesions, and it could also be useful for identifying vascular lesions. During

initial trauma assessment, computerized tomography is a common diagnostic method [1, 2, 5, 7, 8]. Magnetic resonance angiography has the ability to produce images of the neck and head simultaneously and to detect early cerebral infarction without the use of contrast [1, 5, 8, 9]. In the 1990′s, studies using angiography as a diagnostic method in populations at risk for BCVI demonstrated that these lesions are rare, corresponding to 1% of all blunt traumas admitted to hospital. Due to limited experience with BCVI in trauma centers, standardized diagnostic and therapeutic approaches to these injuries have not been established. Furthermore, the current approach to BCVI classification has not been unanimously accepted. These limitations have restricted the development of a practical, safe, and universal approach to handling BCVI cases [5].

Although BCVI treatment approaches are debated, all current modalities of treatment, whether clinical or endovascular, depend on the clinical situation, the experience of the medical team, and, above all, the exact characterization of the location and severity of the lesion using an appropriate diagnostic method. Objective To evaluate the accuracy of criteria used to recommend angiotomography Miconazole in the diagnosis of cervical BCVI in 100 patients with blunt cervical trauma in the trauma services section of a Brazilian quaternary care hospital. Materials and methods The current study was approved by the Ethics Committee for Analysis of Research Projects – CAPPesq of the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. It is based on data obtained from medical records of patients who suffered blunt trauma and were admitted to the Emergency Department of the Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP) from July 2006 to December 2008 using clinical and/or radiographic data that indicated a potential risk of BCVI. Inclusion criteria in the current study were designed based on eleven previously published criteria.

BL21/pES2KI pellets were subjected to ammonium sulfate precipitat

BL21/pES2KI pellets were subjected to ammonium sulfate precipitation (30-40%), resuspended in buffer A (30 mM NaCl and 20 mM Tris-Cl, pH 8.0), and applied to a Fractogel column (Merck, USA). The fraction

was eluted by a NaCl gradient (30 mM-1.4 M). After purification through a P-100 size-exclusion column (BioRad, USA), the CaroS2K fractions were Poziotinib ic50 pooled and concentrated using an Amicon centriprep-50 column (Millipore, USA) and dissolved in buffer A. BL21/pES2I pellets were precipitated by ammonium sulfate (70-100%) and resuspended in buffer A. CaroS2I purification involved a similar chromatographic procedure using the Amicon centriprep-3 column (Millipore, USA). The concentration of protein was determined by the Bradford assay (Amresco, USA). In vitro determination of Carocin S2 activity Total RNA was treated with calf intestinal alkaline phosphatase (Promega, USA) at 55°C for 30 min as recommended by the manufacturer. The reaction was arrested by adding 5 mM nitrilotriacetic acid, and RNA was extracted with equal volumes of phenol/chloroform. An aliquot of phosphatase-treated RNA was 5′-32P-labeled at 37°C for 30 min by incubation with a mixture of [γ-32P]ATP, T4 polynucleotide kinase (Promega Inc, USA), and reaction buffer in nuclease-free water [42]. [5'-32P]Cytidine 3′,5′-bisphosphate (pCp) and T4 RNA ligase

(Promega, USA) were used for 3′-labeling of RNA [43]. Subsequently, the mixture was purified by MicroSpin G-25 columns (GE Healthcare, USA). The purified labeled RNA was divided into aliquots and incubated without or with Carocin S2 at 28°C for

60 min, respectively. To measure Selleckchem Ceritinib its activity, CaroS2I was pre-mixed with an equal amount of CaroS2K. The mixtures were subjected to electrophoresis on a 9% polyacrylamide gel (19:1) containing 7M urea, 50 mM Tris, 50 mM boric acid, and 1 mM EDTA, pH 8.3. All samples were electrophoresed at 15℃ by PROTEIN II xi (BioRad, USA). To confirm DNase activity, 1 μg of genomic DNA from SP33 in solution containing Fossariinae buffer A was incubated with or without Carocin S2 at 28°C for 90 min. An equal quantity of genomic DNA was digested with EcoRI at 28°C for 90 min. Samples were then subjected to electrophoresis on 1% agarose gel. Antibiotic activity of Carocin S2 Overnight cultures of SP33 were diluted (1:100) with LB medium and grown at 28°C to a density of approximately 105 CFU ml-1. The activity of increasing concentrations of Carocin S2 on cells in suspension incubated at 28°C for 60 min was assessed. CaroS2I was pre-mixed with an equal molar ratio of CaroS2K. All reaction mixtures were spread onto LB agar plates and incubated at 28°C for 16 h. The experiment was performed three times. Colonies growing on a series of plates were respectively counted. Computer analysis of sequence data Sequencing of the DNA fragments was carried out using an ABI automated DNA sequencer 373S.

Arnold MS, Avouris P, Pan ZW, Wang ZL: Field-effect transistors b

Arnold MS, Avouris P, Pan ZW, Wang ZL: Field-effect transistors based on single semiconducting oxide nanobelts. J Phys Chem B 2003, 107:659–663.CrossRef 2. Colli A, Fasoli A, Ronning C, Pisana S, Piscanec S, Ferrari AC: Ion beam doping of silicon nanowires. Nano Lett 2008, 8:2188–2193.CrossRef 3. Martel R, Schmidt T, Shea H, Hertel T, Avouris P: Single-and multi-wall Decitabine carbon nanotube field-effect transistors. Appl Phys Lett 1998, 73:2447–2449.CrossRef 4. Cui Y, Zhong Z, Wang D, Wang WU, Lieber CM: High performance silicon nanowire field effect transistors. Nano Lett 2003, 3:149–152.CrossRef 5. Wang ZL, Song J: Piezoelectric nanogenerators based on zinc oxide nanowire arrays. Science

2006, 312:242–246.CrossRef 6. Feng X, Shankar K, Varghese OK, Paulose M, Latempa TJ, Grimes CA: Vertically aligned

single crystal TiO2 nanowire arrays grown directly on transparent conducting oxide coated glass: synthesis details and applications. Nano Lett 2008, 8:3781–3786.CrossRef 7. Chu WH, Liu CP: Electrical properties of a single p-type ZnO nanowire by Ga implantation with FIB. In IEEE 4th International Nanoelectronics Conference (INEC): 21–24 June 2011; Tao-Yuan. New York: IEEE; 2011:1–2. 8. Cheng Y, Liang Y, Lei M, Hark SK, Wang N: Modification of structure and optical property of ZnO nanowires by Ga ion beam. In MRS Proceedings, Volume 1201. Edited by: Durbin SM, von Wenckstern H, Allen M. Cambridge: Cambridge University Nutlin-3 supplier Press; 2009. 9. Borschel C, Niepelt R, Geburt S, Gutsche C, Regolin I, Prost W, Tegude FJ, Stichtenoth D, Schwen D, Ronning C: Alignment of semiconductor nanowires using ion beams. Small 2009, 5:2576–2580.CrossRef

selleck kinase inhibitor 10. Jun K, Joo J, Jacobson JM: Focused ion beam-assisted bending of silicon nanowires for complex three dimensional structures. J Vac Sci Techno B 2009, 27:3043–3047.CrossRef 11. Ziegler JF, Biersack J, Littmark U: The Stopping and Range of Ions in Solids. New York: Pergamon Press; 1985. 12. Dhara S, Datta A, Wu C, Lan Z, Chen K, Wang Y, Chen L, Hsu C, Lin H, Chen C: Enhanced dynamic annealing in Ga ion-implanted GaN nanowires. Appl Phys Lett 2003, 82:451–453.CrossRef 13. Tuboltsev V, Räisänen J: Sculpturing nanowires with ion beams. Small 2009, 5:2687–2691.CrossRef 14. Sigmund P: Theory of sputtering. I. Sputtering yield of amorphous and polycrystalline targets. Phys Rev 1969, 184:383.CrossRef 15. Harper JME: Theory of ripple topography induced by ion bombardment. J Vac Sci Technol A 1988, 6:2390–2395.CrossRef 16. Wang J, Zhou M, Hark S, Li Q, Tang D, Chu M, Chen C: Local electronic structure and luminescence properties of Er doped ZnO nanowires. Appl Phys Lett 2006, 89:221917–221919.CrossRef 17. Stichtenoth D, Wegener K, Gutsche C, Regolin I, Tegude F, Prost W, Seibt M, Ronning C: P-type doping of GaAs nanowires. Appl Phys Lett 2008, 92:163107–163109.CrossRef 18. Ronning C, Carlson E, Davis R: Ion implantation into gallium nitride. Phys Rep 2001, 351:349–385.CrossRef 19.

A 31P NMR study Biochimie 85:885–890PubMed 131 Lanza IR, Befroy

A 31P NMR study. Biochimie 85:885–890PubMed 131. Lanza IR, Befroy DE, Kent-Braun JA (2005) Age-related changes in ATP-producing pathways in human skeletal muscle in vivo. J Appl Physiol 99:1736–1744PubMed 132. Lanza IR, Wigmore DM, Befroy DE, Kent-Braun JA (2006) In vivo

ATP production during free-flow and ischaemic muscle contractions in humans. J Physiol 577:353–367PubMed 133. Mairiang E, Hanpanich P, Sriboonlue P (2004) In vivo 31P-MRS assessment of muscle-pH, cytosolic-[Mg2+] and phosphorylation potential after supplementing hypokaliuric renal stone patients with potassium and magnesium salts. Magn Reson Imaging 22:715–719PubMed 134. Taylor JH, Beilman GJ, Conroy

MJ, Mulier KE, Myers D, Gruessner A, Hammer BE (2004) Tissue energetics Protein Tyrosine Kinase inhibitor as measured by nuclear magnetic resonance spectroscopy during hemorrhagic shock. Shock 21:58–64PubMed 135. Delmas-Beauvieux MC, Quesson B, Thiaudiere E, Gallis JL, Canioni P, Gin H (1999) 13C HM781-36B mouse nuclear magnetic resonance study of glycogen resynthesis in muscle after glycogen-depleting exercise in healthy men receiving an infusion of lipid emulsion. Diabetes 48:327–333PubMed 136. Hunter GR, Newcomer BR, Larson-Meyer DE, Bamman MM, Weinsier RL (2001) Muscle metabolic economy is inversely related to exercise intensity and type II myofiber distribution. Muscle Nerve 24:654–661PubMed 137. Krssak M, Petersen KF, Bergeron R, Price T, Laurent D, Rothman not DL, Roden M, Shulman GI (2000) Intramuscular glycogen and

intramyocellular lipid utilization during prolonged exercise and recovery in man: a 13C and 1H nuclear magnetic resonance spectroscopy study. J Clin Endocrinol Metab 85:748–754PubMed 138. Meynial-Denis D, Miri A, Bielicki G, Mignon M, Renou JP, Grizard J (2005) Insulin-dependent glycogen synthesis is delayed in onset in the skeletal muscle of food-deprived aged rats. J Nutr Biochem 16:150–154PubMed 139. Rico-Sanz J, Zehnder M, Buchli R, Dambach M, Boutellier U (1999) Muscle glycogen degradation during simulation of a fatiguing soccer match in elite soccer players examined noninvasively by 13C-MRS. Med Sci Sports Exerc 31:1587–1593PubMed 140. Rico-Sanz J, Zehnder M, Buchli R, Kuhne G, Boutellier U (1999) Noninvasive measurement of muscle high-energy phosphates and glycogen concentrations in elite soccer players by 31P- and 13C-MRS. Med Sci Sports Exerc 31:1580–1586PubMed 141. Rotman S, Slotboom J, Kreis R, Boesch C, Jequier E (2000) Muscle glycogen recovery after exercise measured by 13C-magnetic resonance spectroscopy in humans: effect of nutritional solutions. MAGMA 11:114–121PubMed 142. Shulman RG, Rothman DL (2001) 13C NMR of intermediary metabolism: implications for systemic physiology. Annu Rev Physiol 63:15–48PubMed 143.